Delivery Order SPE2DB22D1017-SPE2DB25FYPCF
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $5,926.63 to AmerisourceBergen Drug Corp for the supply of Carvedilol ER 20 mg capsules (30-count units) on August 20, 2025, with an ultimate completion date of August 21, 2025. The contract is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. Performance will be conducted at the contractor's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency awarded a delivery order valued at $4,578.12 to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Carvedilol ER 10 mg capsules (30-count units). This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open competition. The order is scheduled for completion by August 22, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Carvedilol ER 20 mg capsules (30-count units) valued at $28,718.73. This non-set-aside, competitively awarded contract features firm fixed pricing and is scheduled for completion by August 4, 2025. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate...
- The Defense Logistics Agency awarded a delivery order valued at $5,210.71 to AmerisourceBergen Drug Corp on August 23, 2025, for the supply of Carvedilol ER 20 mg capsules (30-count units). This is a firm fixed-price delivery order with a completion deadline of August 25, 2025, and represents a non-set-aside competitive procurement. The award will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,174.62 to AmerisourceBergen Drug Corp for Carvedilol ER 10 mg capsules (30-count) on August 15, 2025, with an ultimate completion date of August 18, 2025. This firm fixed-price, non-set-aside contract represents a small-value pharmaceutical delivery under the company's existing indefinite delivery contract vehicle with DLA Troop Support Medical. The product will be performed at the contractor's facility in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $7,054.82 to AmerisourceBergen Drug Corp for the supply of Carvedilol ER 10 mg capsules (30-count units) on July 23, 2025, with an ultimate completion date of July 24, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical procurement...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Carvedilol ER 20 mg capsules (30-count units) with a ceiling value of $2,756.79 and an ultimate completion date of July 28, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded competitively under AmerisourceBergen's existing contract vehicle. The performance location is the company's Conshohocken, Pennsylvania facility, where...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Carvedilol ER 20 mg capsules in 30-count quantities, with a ceiling value of $14,592.37. This is a firm fixed price delivery order with no set-aside designation, executed as a competitive award under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical. The contract performance location is AmerisourceBergen's corporate office in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Carvedilol ER 20 mg capsules (30-count units) under a firm fixed price contract valued at $1,914.87. The award, issued on August 13, 2025, represents a competitive procurement with no set-aside designation and an ultimate completion date of August 14, 2025. Performance will be executed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order operates as a...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Carvedilol ER 10 mg capsules (30-count packaging). The contract is valued at $9,434.27 under a firm fixed-price arrangement with an ultimate completion date of August 15, 2025. This delivery order was awarded competitively with no set-aside designation and represents performance at AmerisourceBergen's corporate office location in Conshohocken,...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB25FYPCFDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $12,904.18 to AmerisourceBergen Drug Corp for the supply of Carvedilol ER 20 mg capsules (30-count units) under a firm fixed price contract type. The award, issued on August 25, 2025, with an ultimate completion date of August 26, 2025, represents a non-competitive, non-set-aside procurement executed through the company's existing contract vehicle. Performance will take place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical prime vendor agreement valued at $999,999,999.00 and extending through December 2026. This strategic vehicle enables the contractor to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs globally, serving entities including the Defense Health Agency and U.S. Coast Guard. AmerisourceBergen's demonstrated capability in federal pharmaceutical procurement, combined with its significant IDC capacity, positions it as a critical vendor within the DLA Medical Supply Chain infrastructure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.9k | 8/25/25 |